Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemia.
Cervetti
Giulia
G
Carulli
Giovanni
G
Galimberti
Sara
S
Azzarà
Antonio
A
Buda
Gabriele
G
Orciuolo
Enrico
E
Pelosini
Matteo
M
Petrini
Mario
M
D000328:Adult; D000741:Anemia, Aplastic / Q000139:chemically induced*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate